首页 /科研细胞 /科研细胞 /科研细胞 /HCC1428(人乳腺腺癌细胞)

HCC1428(人乳腺腺癌细胞)

CBP60412

询 价
索取STR
产品描述
产品数据库
I. General information 
Synonyms: HCC1428
Background: HCC1428 was derived from a female who harbored a homozygous deletion in the FHIT gene.
This cell line was initiated on 11/4/95 and took 15 months to establish.
Species: Homo sapiens, human
Tissue: mammary gland/breast; derived from metastatic site: adenocarcinoma and pleural effusion
Disease: TNM stage IV, grade 4, adenocarcinoma
Gender: Caucasian, White, 49 years, female
Morphology: epithelial
Growth Mode: adherent
Doubling Time: N/A
DNA Profile: CSF1PO: 10
D13S317: 12
D16S539: 12,8
D5S818: 11,12
D7S820: 9
THO1: 8
TPOX: 8
vWA: 17
Cobioer’s Cell Line Authentication Service
Culture Medium:

RPMI-1640+10%FBS

HCC1428完全培养基,# CBP60412M
We strongly suggest to purchase the complete medium from Cobioer.

Cryopreservation medium: 90%FBS+10%DMSO
Antigen Expression: N/A
Receptor Expression: N/A
Oncogene: her2/neu -, p53 -
Genes Expressed: HCC1428 cells are positive for the expression of Epithelial glycoprotein 2 [EGP2]; cytokeratin 19
The cells are negative for expression of Her2-neu and for expression of p53.
Cellular Products: N/A
Tumor Formation: N/A
Comments: An EBV transformed lymphoblastoid cell line [HCC1428 BL] from the same patient is available as ATCC CRL-2328. The homozygous deletion in the FHIT gene is retained in the lymphoblastoid line.
The FHIT gene, which spans the FRA3B fragile site at chromosome 3p14.2, is a candidate tumor suppressor gene in breast and other cancers.
For more information, please contact Cobioer (4008-750-250).
药靶模型联系方式: 华东销售经理:18240630236 全国销售经理:18066071954
诊断标准品联系方式: 华东销售经理:15000320447 华北销售经理:18131625521 华南销售经理:13484295986 华中&西南销售经理:13871580511 全国销售经理:13484295986

扫二维码

立即提交